Search
ST101 peptide
go.drugbank.com/drugs/DB17272ExperimentalST101 is a cell-penetrating peptide that disrupts the protein-protein interactions driving ATF5-regulated gene transcription.
Lutetium Lu177 Edotreotide
go.drugbank.com/drugs/DB17278InvestigationalSynonyms: Dotatoc Lu-177, Edotreotide lutetium Lu-177Categories: Compounds used in a research, industrial, or household settingIMAB027
go.drugbank.com/drugs/DB17282InvestigationalIMAB027 is a chimeric monoclonal antibody against Claudin 6.
YS-ON-001
go.drugbank.com/drugs/DB17291InvestigationalYS-ON-001 is a combination of an inactivated purified rabies virus (IPRV) and the PIKA adjuvant (Poly I:C, kanamycin and calcium).
Hiltonol
go.drugbank.com/drugs/DB17293InvestigationalSynonyms: 5'-cytidylic acid, homopolymer, complex with 5'-inosinic acid homopolymer (1:1), compd. with cellulose carboxymethyl ether and l-lysine homopolymer, 5'-inosinic acid, homopolymer, complex with 5'-cytidylic acid homopolymer (1:1), compd. with cellulose carboxymethyl ether and l-lysine homopolymerCategories: Poly C, Poly ITavokinogene telseplasmid
go.drugbank.com/drugs/DB17301InvestigationalTavokinogene telseplasmid consists of a DNA Plasmid Vector Encoding IL-12.
Synonyms: Dna plasmid containing genes coding for the human interleukin 12 (il-12) p35 and p40 subunits that are separated by an internal ribosomal entry site (ires) and under the control of a single cytomegalovirusSNS01-T
go.drugbank.com/drugs/DB17302InvestigationalSNS01-T is a gene therapy nanoparticle. … It is composed of three components: a B cell-specific plasmid expressing eIF5AK50R; an siRNA that targets the native eIF5A that promotes growth/anti-apoptosis of cancer cells; and polyethylenimine.
Laurocapram
go.drugbank.com/drugs/DB17308ApprovedSynonyms: 1-n-dodecylazacycloheptan-2-one, 1-dodecylazacycloheptan-2-oneCategories: Heterocyclic Compounds, 1-RingMaveropepimut-S
go.drugbank.com/drugs/DB17339InvestigationalMaveropepimut-S is a T cell activating immunotherapy.
Synonyms: MVP-S, Maveropepimut SENB-003
go.drugbank.com/drugs/DB17340InvestigationalENB-003 is a selective and potent inhibitor of the endothelin B receptor (ETBR) being investigated for cancer.